patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
HADLIMA
Marketedupdated 2mo agoby Samsung Bioepis Co Ltd
Approvedcommunity read0 votes
all catalysts(12)
approval · 12
Jul 23, 2019
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Jun 17, 2022
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Aug 15, 2022
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Dec 23, 2022
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Apr 26, 2023
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Jun 26, 2023
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Jul 11, 2023
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Jun 28, 2024
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
May 21, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
May 21, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Jun 23, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Oct 17, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that